R. V. Shutov et al. / Tetrahedron Letters 52 (2011) 266–269
269
5H, Ph), 7.71 (dd, 1H, CH-8, J = 7.6 Hz, 1.8 Hz), 7.83 (d, 1H, CH-10,
2.4. General procedure for 60-chloro- or 60-bromopyran-
othiazine-4,7-diones 12f,g in glacial acetic acid
J = 1.9 Hz), 8.06 (d, 1H, C-5OH, J = 6.0 Hz), 8.53 (s, 1H, CH-4),
12.75 (s, 1H, NH); 13C NMR (125 MHz, DMSO-d6) d 91.4 (C-5),
110.8 (C-4A), 115.6 (C-9), 117.4 (C-3), 120.6 (C-7), 125.3 (C-10A),
127.4 (C–Ph), 128.6 (C–Ph), 132.4 (C–Ph), 135.4 (C-10), 136.9 (C-
8), 142.3 (C–Ph), 148.5 (C-4), 153.3 (C-10B), 153.7 (C-6A), 160.3
(C-2), 160.8 (C@O), 202.3 (C@S); MS (70 eV): m/z 459 (M+, 81Br,
8%), 457 (M+, 79Br, 8%), 441 (12), 439 (12), 415 (13), 413 (13),
279 (80), 277 (78), 251 (100), 249 (100); IR (KBr) 1169, 1540,
1688, 1720, 3400 cmꢃ1; Anal. Calcd for C20H12BrNO5S: C, 52.42;
H, 2.64; N, 3.06. Found: C, 52.62; H, 2.47; N 3.16.
2-Phenyl-4-hydroxy-6H-1,3-thiazin-6-one (7a) (0.01 mol) was
dissolved in 20 ml of glacial AcOH with heating at 50 °C, and the
respective 6-chloro- or 6-bromo-3-formylchromone 1 was added
(0.011 mol). Heating was continued at 50–60 °C for 2 h with inter-
mittent stirring. The solvent was removed in vacuo (20 mmHg),
EtOH (10 ml) was added to the residue, and the formed precipitate
filtered, washed with EtOH (3 ꢂ 10 ml), and recrystallized from
CH2Cl2–C6H14 (1:1) to give pyranothiazines 12f,g as yellow pow-
ders. Their physical and spectral properties were identical to those
obtained by the previous method.
2.2. 5-(60-Bromo-40-oxo-4H-chromen-30-yl)-2-phenyl-5,6-
dihydro-4H,7H-pyrano[2,3-d][1,3]thiazine-4,7-dione (12g)
Supplementary data
Yield 5%, Mp 246–249 °C; 1H NMR (500 MHz, DMSO-d6) d 2.82
(d, 1H, CH-6B, J = 16.0 Hz), 3.30 (dd, 1H, CH-6A, J = 16.1 Hz,
9.0 Hz), 4.28 (d, 1H, CH-5X, J = 9.0 Hz), 7.45–7.81 (m, 5H, Ph),
7.53 (d, 1H, CH-80, J = 8.1 Hz), 7.78 (d, 1H, CH-70, J = 8.2 Hz), 8.10
(d, 1H, CH-50, J = 1.9 Hz), 8.45 (s, 1H, CH-20); 13C NMR (125 MHz,
DMSO-d6) d 28.1 (C-6), 32.9 (C-5), 103.0 (C-4A), 113.4 (C-30),
118.8 (C-80), 123.3 (C-60), 126.2 (C-4A0), 127.3 (C-Ph), 129.8 (C-
Ph), 130.3 (C-70), 135.4 (C-50), 134.3 (C-Ph), 142.4 (C-Ph), 146.1
(C-20), 156.5 (C-8A0), 164.2 (C-40), 165.6 (C-7), 173.3 (C-8A), 176.8
(C-4), 180.8 (C-2); MS (70 eV): m/z 483 (M+, 81Br, 100%), 481 (M+,
79Br, 90%), 455 (9), 453 (8), 427 (40), 425 (37), 324 (21), 322
(18), 172 (13), 158 (22), 121 (44); IR (KBr) 1190, 1680,
1745 cmꢃ1; Anal. Calcd for C22H12BrNO5S: C, 54.79; H, 2.51; N,
2.90. Found: C, 55.21; H, 2.10; N 3.25.
Supplementary data associated with this article can be found, in
References and notes
1. Gašparová, R.; Lácová, M. Molecules 2005, 10, 937–960.
2. Haas, G.; Stanton, L.; Von Sprecher, A.; Wenk, P. J. Heterocycl. Chem. 1981, 18,
607–612.
3. Sosnovskikh, V. Ya.; Irgashev, R. A. Tetrahedron Lett. 2007, 48, 7436–7439.
4. (a) Nohara, A.; Ishiguto, T.; Sanno, Y. Tetrahedron Lett. 1974, 15, 1183–1186; (b)
Ghosh, C. K.; Khan, S. Synthesis 1981, 903; (c) Jones, W. D.; Albrecht, W. L. J. Org.
Chem. 1976, 41, 706; (d) Bandyophadhyay, C.; Sur, K. R.; Patra, R. J. Chem. Res.
(S) 1998, 12, 802; (e) Ryabukhin, S. V.; Plaskon, A. S.; Volochnyuk, D. M.;
Tolmachev, A. A. Synlett 2004, 2287–2290; (f) Abdel-Rahman, A. H.;
Hammouda, M. A. A.; El-Desoky, S. I. Heteroat. Chem. 2005, 16, 20–27; (g)
Coutinho, D. L. M.; Fernandes, P. S. Indian J. Chem. 1992, 31B, 573–577.
5. (a) Heber, D. Synthesis 1978, 691–692; (b) Ghosh, C. K.; Ray, A.; Patra, A. J.
Heterocycl. Chem. 2001, 38, 1459–1463; (c) Quiroga, J.; Rengifo, A.; Insuasty, B.;
Abonia, R.; Nogueras, M.; Sanchez, A. Tetrahedron Lett. 2002, 43, 9061–9063.
6. (a) Sopova, M. V.; Mikhailov, L. E.; Krylov, A. V.; Ivin, B. A. Russ. J. Gen. Chem.
2007, 77, 155–157; (b) Krylov, A. V.; Sopova, M. V.; Mikhailov, L. E.; Ivin, B. A.
Collection of Abstracts, First International Conference ‘Chemistry and Biological
Activity of Nitrogen Heterocycles and Alkaloids’, Moscow, Oct 9–12, 2001;
Moscow State University: Moscow, 2001; Vol. 2, p 170.
7. Shutov, R.V.; Kaluzhskikh, A. N.; Krylov, A. V.; Sopova, M. V.; Mikhailov, L. E.;
Ivin, B. A. Collection of Papers, International Conference, dedicated to the 85th
anniversary of SPCPA, Saint-Petersburg, Apr 24–28, 2004; Saint-Petersburg
State Chemical Pharmaceutical Academy: Saint-Petersburg, 2001; pp 118–122.
8. Shutov, R. V.; Kaluzhskikh, A. N.; Moskvin, A. V.; Ivin, B. A. Russ. J. Gen. Chem.
2006, 76, 814–821.
9. Shutov, R. V.; Kuklina, E. V.; Ivin, B. A. Russ. J. Gen. Chem. 2009, 79, 1049–1051.
10. Nohara, A.; Umetani, T.; Sanno, Y. Tetrahedron Lett. 1973, 14, 1995–1998.
11. Mironova, G. A.; Kirillova, E. N.; Kuklin, V. N.; Smorygo, N. A.; Ivin, B. A. Chem.
Heterocycl. Compd. (Engl. Transl.) 1984, 20, 1088–1094.
2.3. (2E)-3-(6-Bromo-4-oxo-4H-chromen-3-yl)prop-2-enoic acid
(13g)
Yield 14%, Mp 247–249 °C; 1H NMR (500 MHz, DMSO-d6) d 7.03
(d, 1H, CH-2, J = 16.2 Hz), 7.61 (d, 1H, CH-80, J = 8.2 Hz), 7.73 (d, 1H,
CH-70, J = 8.1 Hz), 7.42 (d, 1H, CH-3, J = 16.0 Hz), 8.03 (d, 1H, CH-50,
J = 1.8 Hz), 8.92 (s, 1H, CH-20), 12.5 (s, 1H, COOH); 13C NMR
(125 MHz, DMSO-d6) d 118.2 (C-2), 121.0 (C-30), 121.7 (C-4A0),
124.0 (C-60), 125.0 (C-70), 131.1 (C-80), 135.1 (C-8A0), 148.1 (C-50),
154.1 (C-20), 159.8 (C-3), 163.5 (C-40), 175.0 (C-1); IR (KBr) 1180,
1680, 2650 cmꢃ1; Anal. Calcd for C12H7BrO4: C, 48.84; H, 2.39.
Found: C, 49.11; H, 2.47.